MicroRNA-126 regulates EPCs function: Implications for a role of miR-126 in preeclampsia

Journal of Cellular Biochemistry

Volumn 114, Issue 9, 2013, Pages 2148-2159

  Yan, Ting ^a   Liu, Yan ^a   Cui, Kai ^a   Hu, Bin ^a   Wang, Fang ^a   Zou, Li ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ENDOTHELIAL PROGENITOR CELLS; MICRORNA 126; PREECLAMPSIA; VASCULOGENESIS

Indexed keywords

ANTAGOMIR; MICRORNA 126; PHOSPHATIDYLINOSITOL 3 KINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; FEMALE; FETUS WEIGHT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

RATTUS;

EID: 84881388732     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24563     Document Type: Article

References (32)

1. -2002. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 99: 159-167.
2. Asahara T,. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-966.
3. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ,. 2005. Real-time quantification of microRNAs by stem-loo pRT-PCR. Nucleic Acids Res 33: e179.
5. Chesley LC,. 1980. Hypertension in pregnancy: Definitions, familial factor, and remote prognosis. Kidney Int 18: 234-240.
6. Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans J-P, Vrints CJ,. 2010. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: Focus on Pi3K/AKT/eNOS pathway. Int J Cardiol 144: 350-366.
7. Fish JE, Santoro MM, Morton SU, Yu S, Yeh R-F, Wythe JD, Ivey KN, Bruneau BG, Stainier DYR, Srivastava D,. 2008. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
8. Fish JE, Srivastava D,. 2009. MicroRNAs: Opening a new vein in angiogenesis research. Sci Signal 2: pe1-pe1.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T,. 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.
10. Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS,. 2007. Identification of a novel role of T cells in postnatal vasculogenesis: Characterization of endothelial progenitor cell colonies. Circulation 116: 1671-1682.
11. Ingram DA,. 2004. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760.
12. Kaufmann P, Mayhew TM, Charnock-Jones DS,. 2004. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 25: 114-126.
13. Li W, Wang H, Kuang C-Y, Zhu J-K, Yu Y, Qin Z-X, Liu J, Huang L,. 2011. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 363: 135-145.
14. Lin C, Rajakumar A, Plymire DA, Verma V, Markovic N, Hubel CA,. 2009. Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia. Am J Hypertens 22: 1014-1019.
15. Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA,. 2010. Maternal circulating CD34 + VEGFR-2+ and CD133 + VEGFR-2 + progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci 17: 643-652.
16. Makeyev EV, Maniatis T,. 2008. Multilevel regulation of gene expression by microRNAs. Science 319: 1789-1790.
17. Mikkola HK, Gekas C, Orkin SH, Dieterlen-Lievre F,. 2005. Placenta as a site for hematopoietic stem cell development. Exp Hematol 33: 1048-1054.
18. Ottersbach K, Dzierzak E,. 2009. Analysis of the mouse placenta as a hematopoietic stem cell niche. Methods Mol Biol 538: 335-346.
19. Redman CW, Sargent IL,. 2005. Latest advances in understanding preeclampsia. Science 308: 1592-1594.
20. Reynolds LP, Borowicz PP, Vonnahme KA, Johnson ML, Grazul-Bilska AT, Wallace JM, Caton JS, Redmer DA,. 2005. Animal models of placental angiogenesis. Placenta 26: 689-708.
21. Roberts JM,. 1998. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 5-15.
22. Roberts JM, Cooper DW,. 2001. Pathogenesis and genetics of pre-eclampsia. Lancet 357: 53-56.
23. Robin C, Bollerot K, Mendes S, Haak E, Crisan M, Cerisoli F, Lauw I, Kaimakis P, Jorna R, Vermeulen M, Kayser M, van der Linden R, Imanirad P, Verstegen M, Nawaz-Yousaf H, Papazian N, Steegers E, Cupedo T, Dzierzak E,. 2009. Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development. Cell Stem Cell 5: 385-395.
24. Shiojima I,. 2002. Role of Akt Signaling in Vascular Homeostasis and Angiogenesis. Circ Res 90: 1243-1250.
25. Sibley CP, Pardi G, Cetin I, Todros T, Piccoli E, Kaufmann P, Huppertz B, Bulfamante G, Cribiu FM, Ayuk P, Glazier J, Radaelli T,. 2002. Pathogenesis of intrauterine growth restriction (IUGR)-conclusions derived from a European Union Biomed 2 concerted action project "importance of oxygen supply in intrauterine growth restricted pregnancies"-A workshop report. Placenta 23 (Suppl. A): S75-S79.
26. Sipos PI, Crocker IP, Hubel CA, Baker PN,. 2010. Endothelial progenitor cells: Their potential in the placental vasculature and related complications. Placenta 31: 1-10.
27. Tanimoto T,. 2002. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR Is Involved in sphingosine 1-phosphate-stimulated phosphorylation of akt and endothelial nitric-oxide synthase (eNOS). J Biol Chem 277: 42997-43001.
28. Thornburg KL, O'Tierney PF, Louey S,. 2010. Review: The placenta is a programming agent for cardiovascular disease. Placenta 31: S54-S59.
29. Ueki K, Fruman DA, Yballe CM, Fasshauer M, Klein J, Asano T, Cantley LC, Kahn CR,. 2003. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278: 48453-48466.
30. Wang F, Wang Y, Zhang L, Zou L,. 2011. Gene modification with integrin-linked kinase improves function of endothelial progenitor cells in pre-eclampsia in vitro. J Cell Biochem 112: 3103-3111.
31. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN,. 2008. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271.
32. Zhang C,. 2010. MicroRNAs in vascular biology and vascular disease. J Cardiovasc Transl Res 3: 235-240.